Does INSULIN GLARGINE-YFGN Cause Device defective? 215 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 215 reports of Device defective have been filed in association with INSULIN GLARGINE-YFGN. This represents 11.9% of all adverse event reports for INSULIN GLARGINE-YFGN.
215
Reports of Device defective with INSULIN GLARGINE-YFGN
11.9%
of all INSULIN GLARGINE-YFGN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Device defective From INSULIN GLARGINE-YFGN?
Of the 215 reports, 3 (1.4%) required hospitalization.
Is Device defective Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INSULIN GLARGINE-YFGN. However, 215 reports have been filed with the FAERS database.
What Other Side Effects Does INSULIN GLARGINE-YFGN Cause?
Device mechanical issue (853)
Product quality issue (426)
Device issue (279)
Device delivery system issue (236)
Product storage error (212)
Wrong technique in product usage process (181)
Device breakage (164)
Incorrect dose administered (152)
Blood glucose increased (115)
Product dose omission issue (110)
What Other Drugs Cause Device defective?
SOMATROPIN (1,719)
USTEKINUMAB (1,071)
SECUKINUMAB (666)
GUSELKUMAB (574)
GOLIMUMAB (539)
ABATACEPT (458)
ALBUTEROL (445)
TOCILIZUMAB (400)
INSULIN GLARGINE (397)
EXENATIDE (387)
Which INSULIN GLARGINE-YFGN Alternatives Have Lower Device defective Risk?
INSULIN GLARGINE-YFGN vs INSULIN GLARGINE\LIXISENATIDE
INSULIN GLARGINE-YFGN vs INSULIN GLULISINE
INSULIN GLARGINE-YFGN vs INSULIN HUMAN
INSULIN GLARGINE-YFGN vs INSULIN LISPRO
INSULIN GLARGINE-YFGN vs INSULIN LISPRO-AABC